✨ Free AI Report
Nightingale Health Oyj: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Nightingale Health Oyj
Company Research

Nightingale Health Oyj: Business Overview, Financials & Competitive Analysis

Nightingale Health Oyj scores 4/10 on the AskCyborg Cyborg Score (Weak). Early-stage health tech with promising diagnostics facing critical challenges in revenue generation, profitability, and market acceptance. Despite innovative technology in health diagnostics, Nightingale faces significant challenges: negative EBITDA of €-9.86M, minimal trailing 12-month revenue of $5.1M, analyst consensus rating of 'Strong Sell', and substantial underperformance relative to market benchmarks.

What is Nightingale Health Oyj's industry? Nightingale Health Oyj (nightingalehealth.com) operates in Health Technology / Diagnostics. AskCyborg classifies Nightingale Health Oyj under Health Technology / Diagnostics in its company registry.

Nightingale Health is a Finnish health technology company that has developed advanced diagnostic tools detecting disease risks from a single blood sample. Operating across Finland, UK, Europe, US, and international ma...

4/ 10Weak

Cyborg Score thesis

Early-stage health tech with promising diagnostics facing critical challenges in revenue generation, profitability, and market...

Read the full analyst-debate transcript →
Industry Health Technology / Diagnostics
3 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Nightingale Health Oyj Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Nightingale Health Oyj

AskCyborg analysts argue the bull and bear cases for Nightingale Health Oyj across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Nightingale Health Oyj OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Nightingale Health Oyj Overview

Pro stress-test →

Nightingale Health is a Finnish health technology company that has developed advanced diagnostic tools detecting disease risks from a single blood sample. Operating across Finland, UK, Europe, US, and international markets, the company leverages proprietary biomarker analysis to enable preventative healthcare and empower individuals with comprehensive health insights.

Strategic Profile

Pro stress-test →

The company positions itself at the intersection of personalized medicine and preventative healthcare, utilizing its proprietary Health Data Platform to detect risks for multiple chronic diseases. Nightingale connects healthcare providers with individuals seeking preventative services, operating through both in-person and remote health check models.

Competitive Landscape

Pro stress-test →

Nightingale competes with GeneDx Holding, Truvian, and Lark in the health diagnostics and preventative healthcare space. The company differentiates through its multi-biomarker blood analysis platform and remote health check capabilities, though faces competitive pressure from established diagnostics companies and well-funded health tech startups.

Industry Context

Nightingale Health Oyj operates in Health Technology / Diagnostics.

Key facts

Founded: 2002 · Headquarters: Helsinki, Finland · Employees: 86 · Revenue: $5.1M · Market cap: $151M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Nightingale Health Oyj.

  • Proprietary blood analysis technology measures broad biomarkers from single sample, differentiating from competitors in disease risk detection
  • Currently unprofitable with significant negative EBITDA (-€9.86M) and minimal revenue ($5.1M TTM), indicating commercialization challenges
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Jan 2023Acquired blood self-collection device technology from Weavr Health (Velvet device)
  • 2025Company maintained operations across expanded geographic footprint including Japan, Singapore, and Nordic expansion
Get alerted when Nightingale Health Oyj has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Nightingale Health Oyj with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Nightingale Health Oyj operates in Health Technology / Diagnostics. See how the rest of the sector scores on the Cyborg framework.

Browse Health Technology / Diagnostics research →
NEW · MCP server

Ask your AI assistant about Nightingale Health Oyj

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Nightingale Health Oyj and its top competitor on Cyborg Score”
“What did Nightingale Health Oyj do this quarter?”
“Is Nightingale Health Oyj a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Nightingale Health Oyj do?+
Nightingale Health is a Finnish health technology company that has developed advanced diagnostic tools detecting disease risks from a single blood sample. Operating across Finland, UK, Europe, US, and international ma...
What is Nightingale Health Oyj's Cyborg Score?+
Nightingale Health Oyj has a Cyborg Score of 4/10 (Weak). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Nightingale Health Oyj's main competitors?+
Named competitors include GeneDx Holding, Truvian, Lark. The full competitive landscape is in the AskCyborg report.
How can I get the full Nightingale Health Oyj research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Nightingale Health Oyj research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Nightingale Health Oyj over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual